Stocks · News reference
GE HealthCare Launches Invenia ABUS Prime And ABUS StreamVue, Expanding Breast Imaging Portfolio With Solutions To Support Supplemental Screening For Women
Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles marks one of the first in the U.S., expanding access to supplemental
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
GE HealthCare Unveils Next-Gen Vivid Cardiovascular Ultrasound Portfolio, With Vivid Explorer, Vivid Advanced And Vivid Focus, For Advanced Imaging Across Cardiology Care Settings
Vivid™ Explorer, Vivid™ Advanced and Vivid™ Focus systems bring cSound™ imaging with capabilities designed for routine echocardiography, comprehensive cardiac imaging and interventional careGE HealthCare (NASDAQ:GEHC)
FDA Announces GE Healthcare Issues Early Alert For Portrait Core Services Software Issue
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-portrait-core-services-software-issue-ge-healthcare
BTIG Reiterates Buy on GE HealthCare Techs, Maintains $79 Price Target
BTIG analyst Ryan Zimmerman reiterates GE HealthCare Techs (NASDAQ:GEHC) with a Buy and maintains $79 price target.